Canlyniadau Chwilio - Salese, Leonardo

Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States gan Long, Millie D, Smith, Timothy W, Dibonaventura, Marco, Gruben, David, Bargo, Danielle, Salese, Leonardo, Quirk, Daniel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Review of the epidemiology and burden of ulcerative colitis in Latin America gan Kotze, Paulo Gustavo, Steinwurz, Flavio, Francisconi, Carlos, Zaltman, Cyrla, Pinheiro, Marcia, Salese, Leonardo, Ponce de Leon, Dario

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open gan Panaccione, Remo, Abreu, Maria T., Lazariciu, Irina, Mundayat, Rajiv, Lawendy, Nervin, Salese, Leonardo, Woolcott, John C., Sands, Bruce E., Chaparro, María

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe gan Armuzzi, Alessandro, Tarallo, Miriam, Lucas, James, Bluff, Daniel, Hoskin, Benjamin, Bargo, Danielle, Cappelleri, Joseph C., Salese, Leonardo, daCosta DiBonaventura, Marco

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies gan Dubinsky, Marla C, DiBonaventura, Marco, Fan, Haiyun, Bushmakin, Andrew G, Cappelleri, Joseph C, Maller, Eric, Thorpe, Andrew J, Salese, Leonardo, Panés, Julian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe gan Armuzzi, Alessandro, DiBonaventura, Marco daCosta, Tarallo, Miriam, Lucas, James, Bluff, Daniel, Hoskin, Benjamin, Bargo, Danielle, Cappelleri, Joseph C., Quirk, Daniel, Salese, Leonardo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management gan Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials gan Panés, Julian, Vermeire, Séverine, Dubinsky, Marla C, Loftus, Edward V, Lawendy, Nervin, Wang, Wenjin, Salese, Leonardo, Su, Chinyu, Modesto, Irene, Guo, Xiang, Colombel, Jean-Frederic

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis gan Chiorean, Michael V., Allegretti, Jessica R., Sharma, Puza P., Chastek, Benjamin, Salese, Leonardo, Bell, Elizabeth J., Peterson-Brandt, Jesse, Cappelleri, Joseph C., Guo, Xiang, Khan, Nabeel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis gan Chiorean, Michael V., Allegretti, Jessica R., Sharma, Puza P., Chastek, Benjamin, Salese, Leonardo, Bell, Elizabeth J., Peterson-Brandt, Jesse, Cappelleri, Joseph C., Guo, Xiang, Khan, Nabeel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials gan Feagan, Brian G., Khanna, Reena, Sandborn, William J., Vermeire, Séverine, Reinisch, Walter, Su, Chinyu, Salese, Leonardo, Fan, Haiyun, Paulissen, Jerome, Woodworth, Deborah A., Niezychowski, Wojciech, Sands, Bruce E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme gan Winthrop, Kevin L, Loftus, Edward V, Baumgart, Daniel C, Reinisch, Walter, Nduaka, Chudy I, Lawendy, Nervin, Chan, Gary, Mundayat, Rajiv, Friedman, Gary S, Salese, Leonardo, Thorpe, Andrew J, Su, Chinyu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open gan Sands, Bruce E., Armuzzi, Alessandro, Marshall, John K., Lindsay, James O., Sandborn, William J., Danese, Silvio, Panés, Julián, Bressler, Brian, Colombel, Jean‐Frédéric, Lawendy, Nervin, Maller, Eric, Zhang, Haiying, Chan, Gary, Salese, Leonardo, Tsilkos, Konstantinos, Marren, Amy, Su, Chinyu

Cael y testun llawn Cael y testun llawn Cael y testun llawn